VTRS
NASDAQ · Pharmaceuticals
Viatris Inc
$15.38
+0.01 (+0.07%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+24.84%
1Y
+73.79%
YTD
+23.43%
Open$15.45
Previous Close$15.37
Day High$15.52
Day Low$15.07
52W High$17.53
52W Low$8.63
Volume—
Avg Volume10.18M
Market Cap17.90B
P/E Ratio—
EPS$-0.26
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$13.14
Above
SMA 200
$10.55
Above
RSI (14)
87.6
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
18 analysts
Price Target
+698.6% upside
Current
$15.38
$15.38
Target
$122.82
$122.82
$69.38
$122.82 avg
$167.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.22B | 14.85B | 3.47B |
| Net Income | -3,496,452,831 | -3,284,767,795 | 966.90M |
| Profit Margin | -24.6% | -23.4% | 27.9% |
| EBITDA | 32.26M | 31.99M | 1.51B |
| Free Cash Flow | — | — | 925.81M |
| Rev Growth | -4.2% | -4.2% | -2.8% |
| Debt/Equity | 0.98 | 0.98 | 0.35 |
Dividend
Dividend Yield3.09%
Annual Dividend$0.48
Payout Ratio28.5%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,102.08 | +0.32% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $231.29 | +1.27% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $115.48 | +1.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $25.08 | -0.52% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $54.70 | +1.30% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $75.89 | -3.58% | 12.5 | 33.00B |